NUMD Company Profile and Key Details

Dividend and splits history remains an important factor for investors monitoring long-term returns.

The stock is currently mid-range between its 52-week high and low $0.01 and $0.04. With a market capitalization of about $1.92 million, Nu-Med Plus, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-2.29). Key stats such as the average daily volume over the past year has been around 13.62 thousand shares, trading with heavier-than-usual volume. Headquartered in Port Jefferson, NY, Nu-Med Plus, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO William R. Colvin, the company employs approximately 2 people and listed since September 25, 2014. Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments.

Our AI price prediction model suggests that Nu-Med Plus, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Nu-Med Plus, Inc. trading at a premium to the broader market with a P/E of -76.67.

Nu-Med Plus, Inc. trades at a P/E ratio of -76.67, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of -7.18 indicating negative book value, which may reflect financial stress. The P/FCF stands at -35.99, also below market averages.